tiprankstipranks
Trending News
More News >
Enlivex Therapeutics (ENLV)
:ENLV
US Market
Advertisement

Enlivex (ENLV) Stock Forecast & Price Target

Compare
436 Followers
See the Price Targets and Ratings of:

ENLV Financial Forecast

ENLV Earnings Forecast

Next quarter’s earnings estimate for ENLV is -$0.15 with a range of -$0.16 to -$0.15. The previous quarter’s EPS was -$0.25. ENLV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year ENLV has Preformed in-line its overall industry.
Next quarter’s earnings estimate for ENLV is -$0.15 with a range of -$0.16 to -$0.15. The previous quarter’s EPS was -$0.25. ENLV beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.03% of the time in the same period. In the last calendar year ENLV has Preformed in-line its overall industry.
No data currently available

ENLV Sales Forecast

Next quarter’s sales forecast for ENLV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENLV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year ENLV has Preformed in-line its overall industry.
Next quarter’s sales forecast for ENLV is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. ENLV beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.64% of the time in the same period. In the last calendar year ENLV has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ENLV
Ram SelvarajuH.C. Wainwright
H.C. Wainwright
$7
Buy
372.97%
Upside
Reiterated
04/24/25
Enlivex's Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
D. Boral Capital Analyst forecast on ENLV
Jason KolbertD. Boral Capital
D. Boral Capital
$13
Buy
778.38%
Upside
Initiated
08/27/24
Enlivex Therapeutics initiated with a Buy at EF HuttonEnlivex Therapeutics initiated with a Buy at EF Hutton
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ENLV
Ram SelvarajuH.C. Wainwright
H.C. Wainwright
$7
Buy
372.97%
Upside
Reiterated
04/24/25
Enlivex's Promising Clinical Progress and Strategic Collaborations Justify Buy Rating
D. Boral Capital Analyst forecast on ENLV
Jason KolbertD. Boral Capital
D. Boral Capital
$13
Buy
778.38%
Upside
Initiated
08/27/24
Enlivex Therapeutics initiated with a Buy at EF HuttonEnlivex Therapeutics initiated with a Buy at EF Hutton
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Enlivex

1 Month
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
+4.65%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +4.65% per trade.
3 Months
xxx
Success Rate
5/8 ratings generated profit
63%
Average Return
+11.28%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +11.28% per trade.
1 Year
Ram SelvarajuH.C. Wainwright
Success Rate
3/8 ratings generated profit
38%
Average Return
-17.49%
reiterated a buy rating 4 months ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 37.50% of your transactions generating a profit, with an average return of -17.49% per trade.
2 Years
xxx
Success Rate
4/8 ratings generated profit
50%
Average Return
+1.59%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +1.59% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ENLV Analyst Recommendation Trends

Rating
Sep 24
Nov 24
Dec 24
Mar 25
Apr 25
Strong Buy
4
3
2
1
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
3
4
4
1
Strong Sell
0
0
0
0
0
total
4
6
6
5
3
In the current month, ENLV has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. ENLV average Analyst price target in the past 3 months is 7.00.
Each month's total comprises the sum of three months' worth of ratings.

ENLV Stock Forecast FAQ

What is ENLV’s average 12-month price target, according to analysts?
Based on analyst ratings, Enlivex Therapeutics’s 12-month average price target is 7.00.
    What is ENLV’s upside potential, based on the analysts’ average price target?
    Enlivex Therapeutics has 372.97% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ENLV a Buy, Sell or Hold?
          Enlivex Therapeutics has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Enlivex Therapeutics’s price target?
            The average price target for Enlivex Therapeutics is 7.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $7.00 ,the lowest forecast is $7.00. The average price target represents 372.97% Increase from the current price of $1.48.
              What do analysts say about Enlivex Therapeutics?
              Enlivex Therapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of ENLV?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis